Venus Concept Inc. (NASDAQ:VERO – Get Free Report) major shareholder Michael Willingham Masters sold 71,368 shares of the stock in a transaction that occurred on Monday, September 30th. The stock was sold at an average price of $0.64, for a total value of $45,675.52. Following the sale, the insider now directly owns 22,383 shares of the company’s stock, valued at $14,325.12. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.
Michael Willingham Masters also recently made the following trade(s):
- On Wednesday, October 2nd, Michael Willingham Masters sold 94,553 shares of Venus Concept stock. The shares were sold at an average price of $0.53, for a total transaction of $50,113.09.
Venus Concept Stock Down 10.3 %
Shares of VERO stock traded down $0.06 during trading hours on Wednesday, hitting $0.51. 280,173 shares of the company were exchanged, compared to its average volume of 1,024,942. Venus Concept Inc. has a 52 week low of $0.42 and a 52 week high of $2.43. The company has a current ratio of 1.99, a quick ratio of 1.30 and a debt-to-equity ratio of 9.72. The business has a 50 day moving average of $0.61 and a two-hundred day moving average of $0.67. The company has a market capitalization of $3.24 million, a PE ratio of -0.08 and a beta of 0.51.
Institutional Investors Weigh In On Venus Concept
A hedge fund recently raised its stake in Venus Concept stock. Masters Capital Management LLC raised its holdings in shares of Venus Concept Inc. (NASDAQ:VERO – Free Report) by 100.0% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 666,702 shares of the company’s stock after acquiring an additional 333,366 shares during the quarter. Masters Capital Management LLC owned approximately 10.49% of Venus Concept worth $522,000 at the end of the most recent reporting period. 87.41% of the stock is owned by hedge funds and other institutional investors.
About Venus Concept
Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.
Recommended Stories
- Five stocks we like better than Venus Concept
- What Are the FAANG Stocks and Are They Good Investments?
- S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
- How to Find Undervalued Stocks
- Nike’s Post-Earnings Drop Presents a Buying Opportunity
- What is the NASDAQ Stock Exchange?
- Microsoft’s Targeted Upside Might Be Too Good to Ignore
Receive News & Ratings for Venus Concept Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venus Concept and related companies with MarketBeat.com's FREE daily email newsletter.